AN2 Therapeutics Inc. Made Headway

Tue, Sep 27, 2022 at 07:33 PM

AN2 Therapeutics Inc. (ANTX:NASDAQ) soared at $15.5, a gain of 31.1%. On Tue, Sep 27, 2022, ANTX:NASDAQ hit a New 2-Week High of $15.5. The stock got featured on our News Catalysts scanner on Mon, Aug 29, 2022 at 08:35 AM in the 'MISCELLANEOUS' category. From Tue, Sep 13, 2022, the stock recorded 70.00% Up Days and 72.73% Green Days

About AN2 Therapeutics Inc. (ANTX:NASDAQ)

AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs.

Top 10 Gainers:

Avenue Therapeutics, Inc. (ATXI:NASDAQ), 106.25%
Scienjoy Holding Corporation (SJ:NASDAQ), 47.9%
Sonendo Inc. (SONX:NYSE), 42.74%
X4 Pharmaceuticals, Inc. (XFOR:NASDAQ), 40.18%
Antelope Enterprise Holdings Limited (AEHL:NASDAQ), 37.46%
Grove Collaborative Holdings Inc. Class A (GROV:NYSE), 35.47%
InMed Pharmaceuticals Inc. (INM:NASDAQ), 31.31%
AN2 Therapeutics Inc. (ANTX:NASDAQ), 31.13%
Intelligent Living Application Group Inc. (ILAG:NASDAQ), 28.43%
Harrow Health, Inc. (HROW:NASDAQ), 27.86%